Can Health Care Be Affordable?

Micrograph of a prostate biopsy showing prosta...

Image via Wikipedia

A federal advisory committee said Wednesday that there was adequate evidence that the drug Provenge prolongs the lives of men with advanced prostate cancer, an endorsement that makes it more likely that Medicare will pay for the $93,000 treatment.

The Medicare Coverage Advisory Committee voted that it had “intermediate confidence’’ in the strength of the data that the drug, developed by Dendreon, improves survival.

This is why health insurance can  only get more expensive, at least so long as we want it to cover every kind of treatment.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: